Phase I Study of Oxaliplatin, Full-Dose Gemcitabine, and Concurrent Radiation Therapy in Pancreatic Cancer From February 2004 to April 2006, we evaluated 151 patients with unresectable CLM resistant ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and ...

To the Editor: In 1999, we reported on the results of a randomized study of adjuvant therapy after liver resection for metastatic colorectal cancer. 1 One group of patients was treated with hepatic ...

Researchers developed a compound that protects the liver after small bowel resection in mice. The drug improved nutrient ...

Background: There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments.

In this study, utilization rates of antiviral therapy were 57% for patients with HBV-associated HCC and 35% for patients with HCV-associated HCC. Antiviral therapy initiated before or within 6 months ...

In this retrospective cohort study, liver resection (LR) showed higher 1-, 3-, and 5-year survival rates than percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE).

High preoperative HBsAg levels are associated with increased recurrence risk after curative resection for HBV-related HCC.

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...